Clinical trials recruiting in Irbid, Jordan

Phase breakdown

Conditions recruiting in Irbid, Jordan

Recruiting trials in Irbid, Jordan

• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
  NCT07012395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
  NCT06632444 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
  NCT05682378 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female)
• Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
  NCT06850727 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• The Effect of Therapeutic Exercise on Cartilage Morphology and Physical Function for Individuals at High Risk of Knee Osteoarthritis
  NCT06532851 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years to 55 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Irbid, Jordan?

5 recruiting trials have at least one study site in Irbid, Jordan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.